Bruker Corporation (BRKR) Price Target Raised to $65 by JPMorgan
Published on · Source: finance.yahoo.com
AI Summary
Summarized by AI from the source belowJPMorgan analyst Casey Woodring raised the price target on Bruker Corporation (BRKR) to $65 from $45 on June 8, maintaining an 'Overweight' rating. Bruker recently reported advancements in its microbiology and infection diagnostics portfolio at ASM Microbe 2026 on June 4. The company has updated its MALDI Biotyper CA System, which can now spot 549 clinically validated microbial species. They also introduced new research tools covering 5,325 species aimed at improving diagnostic workflows, which could enhance clinical decision-making.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
About JPMorgan Chase & Co. (JPM)
JPMorgan Chase is the largest U.S. bank by assets, spanning consumer banking, investment banking, asset management, and payments.
The Financials sector covers banks, insurers and capital-markets firms at the center of the economy.
Earlier JPM news
- JPM (JPM) Names Two New Presidents in Leadership Change
- HB Fuller (FUL) Rating Upgraded on Positive EBITDA Growth Outlook
- JPMorgan (JPM) Appoints Doug Petno and Troy Rohrbaugh as Co-Presidents
- JPMorgan (JPM) CEO Jamie Dimon Advocates In-Office Work for Training
- Goldman Sees $165 Billion Stock Selloff from Hedge Fund Leverage
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
Related News
Aeromexico Plans New US Flights After Washington Lifts Restrictions
Oct 19
SpaceX AI Computing Power Rental Driving Revenue Growth but Raising Costs
Oct 19
JPMorgan (JPM) Cuts Q3 Share Buybacks Amid Growth Focus
Oct 19
JPMorgan Chase (JPM) Stock 8% Below Record High: Analysis
Oct 18